导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 002422 | 科伦药业 | 4.30% | 0.61% | 0.0262% |
| 688180 | 君实生物-U | 4.26% | 6.14% | 0.2616% |
| 603259 | 药明康德 | 4.13% | 6.71% | 0.2771% |
| 688506 | 百利天恒 | 3.43% | 2.91% | 0.0998% |
| 688382 | 益方生物-U | 3.21% | 3.52% | 0.1130% |
| 688202 | 美迪西 | 2.35% | 6.29% | 0.1478% |
| 688710 | 益诺思 | 2.13% | 8.82% | 0.1879% |
| 600276 | 恒瑞医药 | 2.08% | 1.63% | 0.0339% |
| 300347 | 泰格医药 | 2.01% | 2.65% | 0.0533% |
| 688553 | 汇宇制药-W | 1.43% | 4.41% | 0.0631% |
| 重仓股合计:29.33%, 重仓股贡献增长率: 1.2637%, 总持股仓位:95.10%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2026-09-15 | -0.73% | 3.10% |
| 2026-09-14 | 1.91% | 3.10% |
| 2026-09-11 | -2.83% | 3.10% |
| 2026-09-10 | -1.41% | 3.10% |
| 2026-09-09 | -0.77% | 3.10% |
| 2026-09-08 | -0.02% | 3.10% |
| 2026-09-07 | 0.62% | 3.10% |
| 2026-09-04 | -1.13% | 3.10% |
| 基金名称 | 单位净值 | 增长率 |
| 湘财长顺混合发起式A | 0.9682 | 4.0214% |
| 湘财长顺混合发起式C | 0.9451 | 4.0214% |
| 湘财长源股票型A | 1.2238 | 2.9613% |
| 湘财长源股票型C | 1.1823 | 2.9613% |
| 湘财创新成长一年持有期混合A | 0.7302 | 2.7540% |
| 湘财创新成长一年持有期混合C | 0.7122 | 2.7540% |
| 湘财长泽灵活配置混合A | 1.5163 | 2.6392% |
| 湘财长泽灵活配置混合C | 1.4746 | 2.6392% |
| 湘财长兴灵活配置混合A | 0.9618 | 2.0589% |
| 湘财长兴灵活配置混合C | 0.9369 | 2.0589% |
| 基金名称 | 单位净值 | 增长率 |
| 广发新兴成长混合C | 1.7912 | 5.2284% |
| 易方达瑞享混合I | 7.7336 | 4.9934% |
| 易方达瑞享混合E | 6.2573 | 4.9934% |
| 广发新兴成长混合A | 1.8177 | 4.7917% |
| 红土转型精选混合(LOF) | 4.8500 | 4.5477% |
| 红土精选混合C | 4.8469 | 4.5421% |
| 财通多策略福鑫定开混合 | 4.9368 | 4.4177% |
| 宏利成长混合 | 4.5907 | 4.4097% |
| 财通成长优选混合A | 4.2674 | 4.3878% |
| 财通成长优选混合C | 2.4510 | 4.3878% |
